We found that deletion of CNPY3 in human breast cancer cells significantly decreased tumor growth and prolonged survival (Figure 4C,D) and reduced metastasis (Figure 4E), suggesting that CNPY3 may be a potential therapeutic target for cancers. This evidence concerns the gene CNPY3 and breast carcinoma.